NIH-funded research R01 grant

Regulation of a new adipokine that improves insulin sensitivity

Official title: Regulation of Insulin Sensitivity by a Novel Adipokine

Funded at University of California Berkeley · NIH-11358325 · Data updated 2026-11-12

A scientist-led study will explore how a newly found adipokine called NRN1 helps fat tissue control insulin and glucose in adults with obesity and type 2 diabetes.

More Insulin Sensitivity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Berkeley
NIH-funded
Lab location1 site (Berkeley, United States)
Project startJune 5, 2026
Project endApril 30, 2030
Funding year2026
Award (this year)$794,101
NIH project number1R01DK147451-01
Project IDNIH-11358325 on NIH RePORTER

Who could benefit from this research

Could help

Adults with obesity and/or type 2 diabetes who could benefit from improved insulin sensitivity.

Less likely to help

People without metabolic disease or those not affected by insulin resistance may see little direct benefit.

What this research studies

Researchers at UC Berkeley will study NRN1, a protein secreted by fat tissue, to understand how it affects insulin action and glucose use in the body. They will examine NRN1’s role in adipose tissue and how it may communicate with other organs, using experiments in cells and animal models and analyzing human data. The project aims to map the signaling pathways, including FGFR1, that NRN1 uses to influence metabolism, and to see how NRN1 levels change in obesity. Findings could reveal new targets to improve insulin sensitivity and help people manage type 2 diabetes.

Why it matters

Potential benefit: If successful, this work could lead to new ways to boost insulin sensitivity and improve blood sugar control for people with obesity-related diabetes.

How similar studies have gone: Prior research suggests adipokines regulate metabolism, and NRN1 shows promise as a regulator of insulin sensitivity in preliminary data.

Where this research is happening

  • University of California Berkeley
    Berkeley, United States
    Active

Researchers

  • Principal investigator: Kang, Sona — University of California Berkeley
  • Study coordinator: Kang, Sona

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.